Skip to main content

Table 3 Genotypes frequencies in the studied group

From: The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients

ERCC1 C118T % (N)

ERCC1 C8092A % (N)

ERCC2 G312A % (N)

ERCC2 A751C % (N)

CC 27.3 (12)

CC 29.55 (13)

GG 40.9 (18)

AA 46.3 (19)

CT 54.5 (24)

CA 65.91 (29)

GA 52.3 (23)

AC 48.8 (20)

TT 18.2 (8)

AA 4.54 (2)

AA 6.8 (3)

CC 4.9 (2)

Total 44

Total 44

Total 44

Total 41